Two clinical trials (NCT02135042, NCT03668730) showed that EBV DNA could be used to identify patients at high risk for treatment failure and to perform further risk stratification, early treatment modification, or both, before the implementation of CCRT
Reactive Oxygen Species-Triggered Curcumin Release from Hollow Mesoporous Silica Nanoparticles for PM(2.5)-Induced Acute Lung Injury Treatment
Thus, the role of the axis identified here in NAFLD has not been directly tested
[Google Scholar] Takoi K, Koie K, Itoga Y et al
qPCR confirmed miR-29b-3p was downregulated in HCC tissues, inversely correlating with elevated GGCT (Fig
Th hai, Vitamin C cn thit cho vic hp th st, iu ny cng gin tip gip bn gim cn